The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
102318268 10231826 8 F 2015 20160809 20140612 20160811 EXP CA-ROCHE-1408821 ROCHE 0.00 F Y 95.00000 KG 20160811 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
102318268 10231826 1 PS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 800 MG SOLUTION FOR INFUSION
102318268 10231826 2 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 787 MG SOLUTION FOR INFUSION
102318268 10231826 3 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 796 MG SOLUTION FOR INFUSION
102318268 10231826 4 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 794 MG SOLUTION FOR INFUSION
102318268 10231826 5 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) LAST DOSE PRIOR TO CELLULITIS 125276 SOLUTION FOR INFUSION
102318268 10231826 6 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 760 MG SOLUTION FOR INFUSION
102318268 10231826 7 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 794 MG SOLUTION FOR INFUSION
102318268 10231826 8 SS ACTEMRA TOCILIZUMAB 1 Subcutaneous 125472 162 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE /wk
102318268 10231826 9 C CRESTOR ROSUVASTATIN CALCIUM 1 0
102318268 10231826 10 C RAMIPRIL. RAMIPRIL 1 0
102318268 10231826 11 C TIAZAC (CANADA) 2 0
102318268 10231826 12 C WARFARIN WARFARIN 1 0
102318268 10231826 13 C DIGOXIN. DIGOXIN 1 0
102318268 10231826 14 C LASIX FUROSEMIDE 1 0
102318268 10231826 15 C CELEBREX CELECOXIB 1 0
102318268 10231826 16 C METHOTREXATE. METHOTREXATE 1 Oral 0 12.5 MG /wk
102318268 10231826 17 C FOLIC ACID. FOLIC ACID 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
102318268 10231826 1 Rheumatoid arthritis
102318268 10231826 8 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
102318268 10231826 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
102318268 10231826 Cellulitis
102318268 10231826 Dysphagia
102318268 10231826 Limb mass
102318268 10231826 Lower respiratory tract infection
102318268 10231826 Sinusitis
102318268 10231826 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
102318268 10231826 1 20110811 0
102318268 10231826 2 20110908 0
102318268 10231826 3 20121105 0
102318268 10231826 4 20140214 0
102318268 10231826 5 20141007 0
102318268 10231826 6 20150427 0
102318268 10231826 7 20150527 20150625 0
102318268 10231826 8 2015 0